Stocks News

LAST PRICE
363.1950
TODAY'S CHANGE (%)
Trending Down-23.0750 (-5.9738%)

Bid / Lots
360.0000/ 1
Ask / Lots
369.9900/ 20
Open / Previous Close
385.1900 / 386.2700
Day Range
Low 359.1100
High 385.1900
52 Week Range
Low 208.6249
High 417.8150
Volume
619,978
above average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Nov 5, 2024
- United Therapeutics Corporation to Present at the UBS Global Healthcare Conference, from 4:30PM ET on Tuesday Nov 05, 2024 by Dow Jones
  4:30PM ET on Tuesday Nov 05, 2024 by Dow Jones
  Companies Mentioned: UTHR
  
  United Therapeutics Corporation to Present at the UBS Global Healthcare Conference
  SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--November 05, 2024--
Nov 1, 2024
- DJ United Therapeutics Is Maintained at Neutral by Goldman Sachs, from 1:32PM ET on Friday Nov 01, 2024 by Dow Jones
  1:32PM ET on Friday Nov 01, 2024 by Dow Jones
  Companies Mentioned: UTHR
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/UTHR/analyst-ratings
  
  (END) Dow Jones Newswires
  
  November 01, 2024 13:32 ET (17:32 GMT)
Oct 31, 2024
- DJ United Therapeutics Is Maintained at Buy by Ladenburg Thalmann, from 3:07PM ET on Thursday Oct 31, 2024 by Dow Jones
  3:07PM ET on Thursday Oct 31, 2024 by Dow Jones
  Companies Mentioned: UTHR
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/UTHR/analyst-ratings
  
  (END) Dow Jones Newswires
  
  October 31, 2024 15:07 ET (19:07 GMT)
- DJ United Therapeutics Is Maintained at Outperform by Oppenheimer, from 2:18PM ET on Thursday Oct 31, 2024 by Dow Jones
  2:18PM ET on Thursday Oct 31, 2024 by Dow Jones
  Companies Mentioned: UTHR
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/UTHR/analyst-ratings
  
  (END) Dow Jones Newswires
  
  October 31, 2024 14:18 ET (18:18 GMT)
- DJ United Therapeutics Is Maintained at Buy by Argus Research, from 10:23AM ET on Thursday Oct 31, 2024 by Dow Jones
  10:23AM ET on Thursday Oct 31, 2024 by Dow Jones
  Companies Mentioned: UTHR
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/UTHR/analyst-ratings
  
  (END) Dow Jones Newswires
  
  October 31, 2024 10:23 ET (14:23 GMT)

Today
- BioMarin Presents Real-World Evidence Further Supporting Safety and Efficacy of VOXZOGO(R) (vosoritide) in Children with Achondroplasia at the European Society for Paediatric Endocrinology (ESPE) Meeting 2024, from 1 hour ago by PR Newswire
  1 hour ago by PR Newswire
  Companies Mentioned: BMRN
- BioMarin Presents Real-World Evidence Further Supporting Safety and Efficacy of VOXZOGO(R) (vosoritide) in Children with Achondroplasia at the European Society for Paediatric Endocrinology (ESPE) Meeting 2024, from 1 hour ago by Dow Jones
  1 hour ago by Dow Jones
  Companies Mentioned: BMRN
Yesterday
- Wolfe Research Initiates BioMarin Pharmaceutical at Outperform With $95 Price Target, from 7:22AM ET on Friday Nov 15, 2024 by MT Newswires
  7:22AM ET on Friday Nov 15, 2024 by MT Newswires
  Companies Mentioned: BMRN
- DJ BioMarin Pharmaceutical Initiated at Outperform by Wolfe Research, from 5:26AM ET on Friday Nov 15, 2024 by Dow Jones
  5:26AM ET on Friday Nov 15, 2024 by Dow Jones
  Companies Mentioned: BMRN
Nov 14, 2024
- Biomarin Pharmaceutical Insider Sold Shares Worth $350,324, According to a Recent SEC Filing, from 2:47PM ET on Thursday Nov 14, 2024 by MT Newswires
  2:47PM ET on Thursday Nov 14, 2024 by MT Newswires
  Companies Mentioned: BMRN
- Sector Update: Health Care Stocks Advance Pre-Bell Thursday, from 9:20AM ET on Thursday Nov 14, 2024 by MT Newswires
  9:20AM ET on Thursday Nov 14, 2024 by MT Newswires
  Companies Mentioned: IBB, XLV, CLPT, PTCT, BGNE
- Exchange-Traded Funds, Equity Futures Higher Pre-Bell Thursday Ahead of Powell Speech, from 8:27AM ET on Thursday Nov 14, 2024 by MT Newswires
  8:27AM ET on Thursday Nov 14, 2024 by MT Newswires
  Companies Mentioned: GLD, FAS, FAZ, IBB, IGM, IGV, SOXX, IVV, IWM, IYE, IYH, IYJ, IYK, IYW, MUFG, QQQ, SPY, VDC, VHT, VIS, XLE, XLF, XLI, XLK, XLP, XLV, XLY, XSD, RTH, USO, SLV, ASML, XRT, EXI, EH, BITO, UNG, ZK, BGNE, OVV, EEM
- BeiGene to Rename as BeOne Medicines, from 7:08AM ET on Thursday Nov 14, 2024 by MT Newswires
  7:08AM ET on Thursday Nov 14, 2024 by MT Newswires
  Companies Mentioned: BGNE
- BeiGene Unveils Proposed Name Change to BeOne Medicines, Reaffirming Its Mission to Unite Global Community Against Cancer, from 6:00AM ET on Thursday Nov 14, 2024 by Dow Jones
  6:00AM ET on Thursday Nov 14, 2024 by Dow Jones
  Companies Mentioned: BGNE
Nov 13, 2024
- Exact Sciences Insider Bought Shares Worth $1,001,325, According to a Recent SEC Filing, from 6:29PM ET on Wednesday Nov 13, 2024 by MT Newswires
  6:29PM ET on Wednesday Nov 13, 2024 by MT Newswires
  Companies Mentioned: EXAS

United Therapeutics Corp
NASDAQ:UTHRUnited States

Search Criteria

Nov 5, 2024

United Therapeutics Corporation to Present at the UBS Global Healthcare Conference, from 4:30PM ET on Tuesday Nov 05, 2024 by Dow Jones

Nov 1, 2024

DJ United Therapeutics Is Maintained at Neutral by Goldman Sachs, from 1:32PM ET on Friday Nov 01, 2024 by Dow Jones

Oct 31, 2024

DJ United Therapeutics Is Maintained at Buy by Ladenburg Thalmann, from 3:07PM ET on Thursday Oct 31, 2024 by Dow Jones

DJ United Therapeutics Is Maintained at Outperform by Oppenheimer, from 2:18PM ET on Thursday Oct 31, 2024 by Dow Jones

DJ United Therapeutics Is Maintained at Buy by Argus Research, from 10:23AM ET on Thursday Oct 31, 2024 by Dow Jones

Peers Headlines

Today

BioMarin Presents Real-World Evidence Further Supporting Safety and Efficacy of VOXZOGO(R) (vosoritide) in Children with Achondroplasia at the European Society for Paediatric Endocrinology (ESPE) Meeting 2024, from 1 hour ago by PR Newswire

BioMarin Presents Real-World Evidence Further Supporting Safety and Efficacy of VOXZOGO(R) (vosoritide) in Children with Achondroplasia at the European Society for Paediatric Endocrinology (ESPE) Meeting 2024, from 1 hour ago by Dow Jones

Yesterday

Wolfe Research Initiates BioMarin Pharmaceutical at Outperform With $95 Price Target, from 7:22AM ET on Friday Nov 15, 2024 by MT Newswires

DJ BioMarin Pharmaceutical Initiated at Outperform by Wolfe Research, from 5:26AM ET on Friday Nov 15, 2024 by Dow Jones

Nov 14, 2024

Biomarin Pharmaceutical Insider Sold Shares Worth $350,324, According to a Recent SEC Filing, from 2:47PM ET on Thursday Nov 14, 2024 by MT Newswires

Sector Update: Health Care Stocks Advance Pre-Bell Thursday, from 9:20AM ET on Thursday Nov 14, 2024 by MT Newswires

Exchange-Traded Funds, Equity Futures Higher Pre-Bell Thursday Ahead of Powell Speech, from 8:27AM ET on Thursday Nov 14, 2024 by MT Newswires

BeiGene to Rename as BeOne Medicines, from 7:08AM ET on Thursday Nov 14, 2024 by MT Newswires

BeiGene Unveils Proposed Name Change to BeOne Medicines, Reaffirming Its Mission to Unite Global Community Against Cancer, from 6:00AM ET on Thursday Nov 14, 2024 by Dow Jones

Nov 13, 2024

Exact Sciences Insider Bought Shares Worth $1,001,325, According to a Recent SEC Filing, from 6:29PM ET on Wednesday Nov 13, 2024 by MT Newswires